Publications by authors named "Alison Strack"

Claim this Profile
F
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.
Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, Pravien Abeywickrema, Vijayalakshmi Agnani, Alison M Strack

Cell Chem Biol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis.
Alison M Strack, Ester Carballo-Jane, Sheng-Ping Wang, Jiyan Xue, Xiaoli Ping

J Lipid Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing HaloTag Technology to Track the Fate of PCSK9 from Intracellular vs. Extracellular Sources.
Xi Ai, Paul Fischer, Oksana C Palyha, Douglas Wisniewski, Brian Hubbard, Alison M Strack

Curr Chem Genomics· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl/6 mice.
Zhu Chen, Edward A O'Neill, Roger D Meurer, Karen Gagen, Silvi Luell, Alison M Strack

J Cardiovasc Pharmacol Ther· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes.
Liwen Zhang, Timothy McCabe, Jon H Condra, Yan G Ni, Laurence B Peterson, Alison M Strack

Int J Biol Sci· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization.
Harry R Chobanian, Yan Guo, Ping Liu, Thomas J Lanza, Marc Chioda, Alison M Strack

Bioorg Med Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin/kexin type 9.
Michelle Melone, Larissa Wilsie, Oksana Palyha, Alison Strack, Shirya Rashid

J Am Coll Cardiol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoid-1 receptor inhibition prevents the reduction of 24-hour energy expenditure with weight loss.
Alison M Strack, Susan Nicolich, Terry Faidley, Joana Achanfuo-Yeboah, Paul K Cunningham

Metabolism· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity.
Harry R Chobanian, Yan Guo, Ping Liu, Marc Chioda, Thomas J Lanza, Alison M Strack

ACS Med Chem Lett· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia.
Wu Yin, Ester Carballo-Jane, David G McLaren, Vivienne H Mendoza, Karen Gagen, Alison M Strack

J Lipid Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chirality.
Ping Liu, Thomas J Lanza, Marc Chioda, Carrie Jones, Harry R Chobanian, Alison M Strack

ACS Med Chem Lett· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of human ApoB and ApoAI immunoturbidity assays for non-human primate dyslipidemia and atherosclerosis research.
Zhu Chen, Alison M Strack, Alice C Stefanni, Ying Chen, Weizhen Wu

J Cardiovasc Transl Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical species.
David G McLaren, Timothy He, Sheng-Ping Wang, Vivienne Mendoza, Raymond Rosa, Alison Strack

J Lipid Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemia.
Fabian Chen, Vic Maridakis, Edward A O'Neill, Brian K Hubbard, Alison Strack

Biomarkers· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonists.
Liping Wang, James A Hubert, Susan J Lee, Jie Pan, Su Qian, Alison M Strack

Bioorg Med Chem Lett· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9.
Brandon Ason, Samnang Tep, Harry R Davis, Yiming Xu, Glen Tetzloff, Alison Strack

J Lipid Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist.
Qingmei Hong, Raman K Bakshi, Brenda L Palucki, Min K Park, Zhixiong Ye, Alison M Strack

Bioorg Med Chem Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist.
Xiao-Ming Guan, Joseph M Metzger, Liming Yang, Kate A Raustad, Sheng-Ping Wang, Alison M Strack

J Pharmacol Exp Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose.
Ester Carballo-Jane, Zhu Chen, Edward O'Neill, Jun Wang, Charlotte Burton, Alison Strack

Bioorg Med Chem· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments.
Joseph M Metzger, Karen Gagen, Kate A Raustad, Liming Yang, Amanda White, Alison M Strack

Am J Physiol Endocrinol Metab· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity.
Shuwen He, Zhixiong Ye, Peter H Dobbelaar, Raman K Bakshi, Qingmei Hong, Alison M Strack

Bioorg Med Chem Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity.
Shuwen He, Zhixiong Ye, Peter H Dobbelaar, Iyassu K Sebhat, Liangqin Guo, Alison M Strack

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.
Liangqin Guo, Zhixiong Ye, Jian Liu, Shuwen He, Raman K Bakshi, Alison M Strack

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: synthesis, SAR and biological evaluation.
Christina B Madsen-Duggan, John S Debenham, Thomas F Walsh, Lin Yan, Pei Huo, Alison M Strack

Bioorg Med Chem Lett· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity.
Lin Yan, Pei Huo, John S Debenham, Christina B Madsen-Duggan, Julie Lao, Alison M Strack

J Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis